Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.643491
Title: Epidrug-mediated reversal of epigenetic changes associated with pituitary adenomas
Author: Yacqub-Usman, Kiren
Awarding Body: Keele University
Current Institution: Keele University
Date of Award: 2013
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The genesis and outgrowth of pituitary adenomas is consequent to the combined contributions of genetic and epigenetic aberrations. Although the relative contribution of each is not known it is likely that particular aberration may be common or particular to an adenoma subtype(s). The impact of subtype specific changes presents significant challenges for clinical management options. In this thesis the potential impact of epigenetic aberrations, that target the Dopamine D2 Receptor (D2R) and the cytokine, Bone Morphogenic Protein 4 (BMP-4) were investigated. In these cases their expression patterns are frequently comprised in a subtype-specific context. This thesis reports that in pituitary cell lines, reduced expression of D2R and that of BMP4 are associated with CpG island methylation and histone modifications indicative of gene silencing. In these cases, incubation of cells with epidrugs, designed to reverse epigenetic silencing, restores their expression.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.643491  DOI: Not available
Keywords: RM Therapeutics. Pharmacology
Share: